SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

Eli Lilly And Co Announces 52-Week Head-To-Head Data From Taltz Versus Humira Trial In Psoriatic Arthritis Met The Primary And All Major Secondary Endpoints Of The Study

Benzinga · -